T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert, James J. Dignam, Terri S. Armstrong et al. · New England Journal of Medicine · 2014 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

Johanna C. Bendell, Susan M. Domchek, Harold J. Burstein et al. · Cancer · 2003 · 1.3K citations

Medicine, Neurology, Oncology +17

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

Georgina V. Long, Victoria Atkinson, Serigne Lo et al. · The Lancet Oncology · 2018 · 996 citations

Medicine, Immunology, Oncology +13

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ <i>neu</i> –Positive Metastatic Breast Cancer

Antonino Musolino, Nadia Naldi, Beatrice Bortesi et al. · Journal of Clinical Oncology · 2008 · 955 citations · Full text

Medicine, Immunology, Oncology +17

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

Thomas Bachelot, Gilles Romieu, Mario Campone et al. · The Lancet Oncology · 2012 · 742 citations

Medicine, Oncology, Pharmacology +16